Mirum and Incyte Report Positive Phase 2 Results f...
Category : Clinical Trial Update 15 June 2026New Data Highlights Strong Disease Control in Patients with FOP Mirum Pharmaceuticals and Incyte...
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
New Data Highlights Strong Disease Control in Patients with FOP Mirum Pharmaceuticals and Incyte...
TREMFYA Receives New Approval for Inflammatory Bowel Diseases in Egypt Johnson & Johnson has an...
Company Announces Progress in Phase 3 Studies of Insulin Ludefen and Bofanglutide Gan & Lee P...
Belite Bio Reaches Important Regulatory Milestone Belite Bio has announced the completion of its...
Takeda has announced positive topline results from its Phase 3 LATITUDE Atlas study evaluating zasoc...